The use of dietary supplements in a community hospital comprehensive cancer center: Implications for conventional cancer care

Supportive Care in Cancer

Volumn 13, Issue 11, 2005, Pages 912-919

  Gupta, Digant ^a   Lis, Christopher G ^a   Birdsall, Timothy C ^a   Grutsch, James F ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

Cancer; Chemotherapy; Dietary supplements; Interaction

Indexed keywords

ANGELICA SINENSIS EXTRACT; ANTINEOPLASTIC AGENT; CIMICIFUGA RACEMOSA EXTRACT; CITRUS FRUIT EXTRACT; COMFREY EXTRACT; ECHINACEA EXTRACT; EPHEDRA EXTRACT; GARLIC EXTRACT; GERMANDER EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLYCYRRHIZA EXTRACT; GREEN TEA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; JIN BU HUAN EXTRACT; KAVA EXTRACT; PRIMROSE OIL; SABAL EXTRACT; SASSAFRAS EXTRACT; SILYBUM MARIANUM EXTRACT; UNCLASSIFIED DRUG; VALERIAN; VISCUM ALBUM EXTRACT;

ADULT; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; COLORECTAL CANCER; COMMUNITY HOSPITAL; CONSULTATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEALTH PRACTITIONER; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SIDE EFFECT; SOYBEAN; VALIDATION PROCESS;

ADULT; AGED; DEMOGRAPHY; DIETARY SUPPLEMENTS; FEMALE; HEALTH CARE SURVEYS; HERB-DRUG INTERACTIONS; HOSPITALS, COMMUNITY; HUMANS; ILLINOIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; ONCOLOGY SERVICE, HOSPITAL; QUESTIONNAIRES; SELF CARE;

EID: 27144555651     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0820-9     Document Type: Review

References (19)

1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328:246-252
2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M et al (1998) Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280:1569-1575
3. Markman M (2002) Safety issues in using complementary and alternative medicine. J Clin Oncol 20:39S-41S
4. Sparreboom A, Cox MC, Acharya MR, Figg WD (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22:2489-2503
5. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134-138
6. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 12:454-462
7. Ashikaga T, Bosompra K, O'Brien P, Nelson L (2002) Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542-548
8. Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A et al (2003) Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 62:849-853
9. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733-1739
10. Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 116:U296
11. Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F et al (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 85:263-270
12. DiGianni LM, Garber JE, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34S-38S
13. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309:86-89
14. Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R et al (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 161:1521-1524
15. Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM et al (2001) Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19:2439-2448
16. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505-2514
17. Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M et al (2002) Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2:8
18. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18:2515-2521
19. Oneschuk D, Fennell L, Hanson J, Bruera E (1998) The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care 14:21-26